A01K 2267/0325
Animal model for autoimmune diseases
A01K2267/0325 (Animal model for autoimmune diseases) appears on 167 US grants and 225 published applications in this corpus.
Search patents in A01K- Granted patents
- 167
- Published applications
- 225
- Assignees
- 155
- Inventors
- 440
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 11 | 0 |
| 1999 | 5 | 0 |
| 2000 | 9 | 0 |
| 2001 | 8 | 1 |
| 2002 | 4 | 15 |
| 2003 | 5 | 12 |
| 2004 | 8 | 16 |
| 2005 | 4 | 17 |
| 2006 | 11 | 13 |
| 2007 | 8 | 8 |
| 2008 | 6 | 14 |
| 2009 | 4 | 7 |
| 2010 | 8 | 11 |
| 2011 | 3 | 6 |
| 2012 | 6 | 2 |
| 2013 | 1 | 4 |
| 2014 | 3 | 6 |
| 2015 | 4 | 5 |
| 2016 | 5 | 9 |
| 2017 | 11 | 11 |
| 2018 | 4 | 9 |
| 2019 | 5 | 15 |
| 2020 | 5 | 5 |
| 2021 | 4 | 8 |
| 2022 | 3 | 7 |
| 2023 | 3 | 5 |
| 2024 | 6 | 8 |
| 2025 | 5 | 7 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene22 Sep 2026US 12,742,179 B2National Jewish Health
- Mouse having a humanized b-cell activating factor gene3 Feb 2026US 12,538,905 B2Regeneron Pharmaceuticals, Inc.
- Method of determining toxicity of an immunomodulatory drug for use in humans30 Dec 2025US 12,510,548 B2The Jackson Laboratory
- Composition for inducing proliferation or accumulation of regulatory T cells9 Sep 2025US 12,409,196 B2The University of Tokyo
- Methods and compositions for modulating innate lymphoid cell pathogenic effectors2 Sep 2025US 12,402,610 B2Massachusetts Institute of Technology
- Methods And Uses Involving Aquaporin-5 (AQP5)20 Aug 2026US 2026/0243770 A1Agency for Science, Technology and Research
- Method for Treating Ulcerative Colitis or Primary Sclerosing Cholangitis16 Jul 2026US 2026/0199576 A1Kyoto University
- Composition for inducing proliferation or accumulation of regulatory t cells30 Apr 2026US 2026/0115235 A1The University of Tokyo
- Gene therapy30 Apr 2026US 2026/0115317 A1
- Composition for inducing proliferation or accumulation of regulatory t cells11 Dec 2025US 2025/0375488 A1The University of Tokyo
Most cited
By later US patents
- Human CTLA-4 antibodies300US 6,984,720 B1Medarex, Inc. · 2006
- Human CTLA-4 antibodies and their uses142US 7,605,238 B2Medarex, Inc. · 2009
- Compositions and methods for the treatment and diagnosis of immune disorders111US 6,562,343 B1Millennium Pharmaceuticals, Inc. · 2003
- Compositions and methods for the treatment and diagnosis of immune disorders106US 6,414,117 B1Millennium Pharmaceuticals, Inc. · 2002
- Composition for inducing proliferation or accumulation of regulatory T cells98US 9,808,519 B2The University of Tokyo · 2017